Related references
Note: Only part of the references are listed.ICUD-EAU International Consultation on Bladder Cancer 2012: Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
Maximilian Burger et al.
EUROPEAN UROLOGY (2013)
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
Marko Babjuk et al.
EUROPEAN UROLOGY (2013)
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers
Ashish M. Kamat et al.
EUROPEAN UROLOGY (2013)
The 1973 WHO Classification Is More Suitable than the 2004 WHO Classification for Predicting Prognosis in Non-Muscle- Invasive Bladder Cancer
Zhongqing Chen et al.
PLOS ONE (2012)
Extravasation of Intravesical Chemotherapy for Non-Muscle-Invasive Bladder Cancer
Laura S. Mertens et al.
UROLOGIA INTERNATIONALIS (2012)
Bipolar energy for transurethral resection of bladder tumours at low-power settings: initial experience
Narmada P. Gupta et al.
BJU INTERNATIONAL (2011)
Clinical Reliability of the 2004 WHO Histological Classification System Compared With the 1973 WHO System for Ta Primary Bladder Tumors
Federico Pellucchi et al.
JOURNAL OF UROLOGY (2011)
Should All Patients with Non-Muscle-Invasive Bladder Cancer Receive Early Intravesical Chemotherapy after Transurethral Resection? The Results of a Prospective Randomised Multicentre Study
Sigurdur Gudjonsson et al.
EUROPEAN UROLOGY (2009)
An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer
Per-Uno Malmstrom et al.
EUROPEAN UROLOGY (2009)
Optical Biopsy of Human Bladder Neoplasia With In Vivo Confocal Laser Endomicroscopy
Geoffrey A. Sonn et al.
JOURNAL OF UROLOGY (2009)
OPINION: Where next for the endoscope?
Ricardo A. Natalin et al.
NATURE REVIEWS UROLOGY (2009)
Genomics: a preview of genomic medicine
Jose A. Karam et al.
BJU INTERNATIONAL (2008)
Epidemiology and genetic susceptibility to bladder cancer
Xifeng Wu et al.
BJU INTERNATIONAL (2008)
Quality control in transurethral resection of bladder tumours
Harry W. Herr et al.
BJU INTERNATIONAL (2008)
Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder
Richard T. Bryan et al.
BJU INTERNATIONAL (2008)
Is Maintenance Bacillus Calmette-Guerin Really Necessary?
Harry W. Herr
EUROPEAN UROLOGY (2008)
Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer
Kees Hendricksen et al.
EUROPEAN UROLOGY (2008)
Prediction of Progression of Non-Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study
Maximilian Burger et al.
EUROPEAN UROLOGY (2008)
The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: A systematic review of the published results of randomized clinical trials
Richard J. Sylvester et al.
EUROPEAN UROLOGY (2008)
Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: A critical analysis of currently available drugs, treatment schedules, and long-term results
J. Alfred Witjes et al.
EUROPEAN UROLOGY (2008)
Radiation Therapy for Prostate Cancer Increases Subsequent Risk of Bladder and Rectal Cancer: A Population Based Cohort Study
Alan M. Nieder et al.
JOURNAL OF UROLOGY (2008)
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer
Lambertus A. Kiemeney et al.
NATURE GENETICS (2008)
Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update
M. Craig Hall et al.
JOURNAL OF UROLOGY (2007)
Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma
Shahrokh F. Shariat et al.
JOURNAL OF UROLOGY (2007)
Prognostic value of p53 for high risk superficial bladder cancer with long-term followup
P. M. J. Moonen et al.
JOURNAL OF UROLOGY (2007)
Max Nitze, the cystoscope and urology
Harry W. Herr
JOURNAL OF UROLOGY (2006)
Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas
Silvia Hernandez et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
MA Knowles
CARCINOGENESIS (2006)
Bladder cancer: Epidemiology, staging and grading, and diagnosis
Z Kirkali et al.
UROLOGY (2005)
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer:: results from the Spanish Bladder Cancer Study and meta-analyses
M García-Closas et al.
LANCET (2005)
Bacillus Calmette-Guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: A meta-analysis of the published results of randomized clinical trials
RJ Sylvester et al.
JOURNAL OF UROLOGY (2005)
A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: A meta-analysis of published results of randomized clinical trials
RJ Sylvester et al.
JOURNAL OF UROLOGY (2004)
Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome
BWG van Rhijn et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies
R Montironi et al.
JOURNAL OF CLINICAL PATHOLOGY (2003)
The health economics of bladder cancer - A comprehensive review of the published literature
MF Botteman et al.
PHARMACOECONOMICS (2003)
p53 immunohistochemistry as a prognostic marker in bladder cancer -: Playground for urology scientists?
BJ Schmitz-Dräger et al.
EUROPEAN UROLOGY (2000)
Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group study
DL Lamm et al.
JOURNAL OF UROLOGY (2000)
Share Paper
